Ultragenyx Pharmaceutical Inc (RARE)
47.24
+1.22
(+2.65%)
USD |
NASDAQ |
Nov 22, 16:00
46.93
-0.31
(-0.66%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Shareholders Equity (Quarterly): 346.83M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 346.83M |
| June 30, 2024 | 432.42M |
| March 31, 2024 | 140.26M |
| December 31, 2023 | 275.41M |
| September 30, 2023 | 31.71M |
| June 30, 2023 | 129.03M |
| March 31, 2023 | 220.48M |
| December 31, 2022 | 352.49M |
| September 30, 2022 | 468.83M |
| June 30, 2022 | 678.07M |
| March 31, 2022 | 796.42M |
| December 31, 2021 | 922.56M |
| September 30, 2021 | 933.67M |
| June 30, 2021 | 972.17M |
| March 31, 2021 | 1.055B |
| December 31, 2020 | 1.154B |
| September 30, 2020 | 666.19M |
| June 30, 2020 | 695.59M |
| March 31, 2020 | 609.15M |
| December 31, 2019 | 653.76M |
| September 30, 2019 | 727.26M |
| June 30, 2019 | 819.79M |
| March 31, 2019 | 886.73M |
| Date | Value |
|---|---|
| December 31, 2018 | 608.91M |
| September 30, 2018 | 662.60M |
| June 30, 2018 | 703.97M |
| March 31, 2018 | 723.66M |
| December 31, 2017 | 383.45M |
| September 30, 2017 | 365.56M |
| June 30, 2017 | 429.45M |
| March 31, 2017 | 488.48M |
| December 31, 2016 | 473.97M |
| September 30, 2016 | 455.89M |
| June 30, 2016 | 443.90M |
| March 31, 2016 | 489.82M |
| December 31, 2015 | 531.09M |
| September 30, 2015 | 576.76M |
| June 30, 2015 | 319.28M |
| March 31, 2015 | 341.12M |
| December 31, 2014 | 184.94M |
| September 30, 2014 | 199.33M |
| June 30, 2014 | 153.08M |
| March 31, 2014 | 165.71M |
| December 31, 2013 | 50.11M |
| September 30, 2013 | 61.15M |
| December 31, 2012 | 84.34M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
31.71M
Minimum
Sep 2023
1.154B
Maximum
Dec 2020
576.70M
Average
631.46M
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 32.35M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.538B |
| Total Liabilities (Quarterly) | 1.185B |
| Current Ratio | 2.806 |